tiprankstipranks
Trending News
More News >
Multi-Chem Limited (SG:AWZ)
SGX:AWZ
Advertisement

Multi-Chem Limited (AWZ) AI Stock Analysis

Compare
16 Followers

Top Page

SG:AWZ

Multi-Chem Limited

(SGX:AWZ)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 4o)
Rating:73Outperform
Price Target:
S$4.00
▲(17.99% Upside)
Multi-Chem Limited's strong financial performance and attractive valuation are the primary drivers of its overall score. The company's solid profitability, low leverage, and high dividend yield make it appealing, despite the recent decline in revenue growth and neutral technical indicators. The absence of earnings call data and corporate events does not impact the score.

Multi-Chem Limited (AWZ) vs. iShares MSCI Singapore ETF (EWS)

Multi-Chem Limited Business Overview & Revenue Model

Company DescriptionMulti-Chem Limited (AWZ) is a prominent player in the chemical industry, specializing in the development, production, and distribution of a diverse range of chemical products. The company operates across several sectors, including industrial chemicals, specialty chemicals, and agrochemicals, catering to various industries such as manufacturing, agriculture, and pharmaceuticals. Multi-Chem Limited is known for its commitment to innovation and quality, providing tailored solutions to meet the specific needs of its clients while ensuring compliance with environmental regulations.
How the Company Makes MoneyMulti-Chem Limited generates revenue primarily through the sale of its chemical products to various industries. The company's revenue model is based on direct sales, where it supplies bulk chemicals to manufacturers and distributors, as well as through the development of custom formulations for specialized applications. Key revenue streams include industrial chemicals, specialty chemicals, and agrochemical products. Multi-Chem Limited also benefits from strategic partnerships with other businesses in related sectors, enhancing its market reach and allowing for collaborative product development. Additionally, the company may engage in research and development projects funded by government grants or industry collaborations, which can further contribute to its earnings.

Multi-Chem Limited Financial Statement Overview

Summary
Multi-Chem Limited demonstrates strong profitability and financial stability with efficient operations and low leverage. While cash flow growth is positive, the recent decline in revenue growth rate and the need for improved cash flow management are areas to watch. Overall, the company is in a solid financial position with room for growth.
Income Statement
75
Positive
Multi-Chem Limited shows a robust gross profit margin and consistent net profit margin, indicating stable profitability. However, the revenue growth rate has been negative recently, which is a concern. The EBIT and EBITDA margins are healthy, reflecting efficient operations.
Balance Sheet
80
Positive
The company maintains a strong balance sheet with a low debt-to-equity ratio, indicating minimal leverage and financial risk. Return on equity is impressive, showcasing effective use of equity to generate profits. The equity ratio is solid, reflecting a strong equity base relative to total assets.
Cash Flow
70
Positive
Operating cash flow and free cash flow have shown growth, which is positive. The free cash flow to net income ratio is high, indicating good cash conversion. However, the operating cash flow to net income ratio is relatively low, suggesting potential cash flow management challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue647.53M658.42M683.68M616.98M603.64M479.71M
Gross Profit86.52M94.79M97.48M87.01M85.51M71.64M
EBITDA35.08M39.25M42.64M24.22M32.60M20.49M
Net Income28.42M27.12M30.82M20.00M24.96M17.78M
Balance Sheet
Total Assets350.03M402.43M381.61M329.30M298.44M273.41M
Cash, Cash Equivalents and Short-Term Investments71.64M83.82M73.54M69.54M74.41M77.65M
Total Debt1.77M2.19M2.69M3.42M5.01M7.60M
Total Liabilities200.23M248.22M237.40M192.21M168.25M146.58M
Stockholders Equity149.80M155.25M145.25M137.10M130.20M114.53M
Cash Flow
Free Cash Flow47.43M36.12M24.84M10.97M25.78M45.85M
Operating Cash Flow47.81M36.64M25.19M12.12M26.95M47.14M
Investing Cash Flow-374.00K128.00K-304.00K-939.00K-896.00K-1.59M
Financing Cash Flow-25.73M-27.29M-20.35M-14.50M-20.15M-27.18M

Multi-Chem Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.39
Price Trends
50DMA
3.42
Negative
100DMA
3.25
Positive
200DMA
3.07
Positive
Market Momentum
MACD
-0.01
Positive
RSI
46.07
Neutral
STOCH
61.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:AWZ, the sentiment is Negative. The current price of 3.39 is below the 20-day moving average (MA) of 3.44, below the 50-day MA of 3.42, and above the 200-day MA of 3.07, indicating a neutral trend. The MACD of -0.01 indicates Positive momentum. The RSI at 46.07 is Neutral, neither overbought nor oversold. The STOCH value of 61.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:AWZ.

Multi-Chem Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
S$490.09M12.2612.72%16.42%-50.75%-61.46%
73
Outperform
$237.74M19.1725.77%3.43%12.65%54.33%
73
Outperform
€303.62M9.857.46%
68
Neutral
S$602.20M15.489.11%1.68%11.57%0.89%
65
Neutral
S$535.87M39.312.87%4.60%
64
Neutral
S$317.24M32.587.60%0.32%47.45%51.05%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:AWZ
Multi-Chem Limited
3.39
0.83
32.22%
SG:5DD
Micro-Mechanics (Holdings)
1.75
0.16
9.86%
SG:8AZ
Aztech Global Ltd.
0.67
-0.18
-21.18%
SG:AWX
AEM Holdings Ltd.
1.84
0.51
38.35%
SG:E28
Frencken Group Limited
1.57
0.41
35.34%
SG:JLB
Grand Venture Technology Limited
0.94
0.40
74.07%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 24, 2025